Clinical Trial

Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE)

Study acronym: MASTERPIECE
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to find out whether changing the microbes in the bowels of Veterans with cirrhosis and hepatic encephalopathy (a condition that affects the brain as a result of liver problems) using capsules made from microbes from healthy people can prevent future episodes of hepatic encephalopathy.
Trial Details
NCT Number NCT07528690
Lead Sponsor VA Office of Research and Development
Conditions Hepatic Encephalopathy, Cirrhosis
Enrollment 162 participants
Start Date 2026-10-30
Primary Completion 2030-10-31 (estimated)
Study Completion 2031-03-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-14